The Role of Vitamin D in the Pathophysiology of Chronic Failure
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Patients will undergo at baseline and regular intervals:
- clinically indicated bloodwork/urine and echocardiogram testing
- biomarker studies
Upon enrolment in the study patients will be divided into 4 groups normal, mildly deficient
and severely deficient. Normal and mild vitamin D levels will receive no treatment while
severe Vitamin D deficiency will be randomized (50/50) to receive no treatment or vitamin D
treatment. They will be seen in the heart failure clinic every 6 months. The patients will be
followed for 26 months.